| abstract |
Provided is a composition for the treatment of optic nerve disorder, comprising a prostaglandin F2α compound of formula (I): wherein, A is -COOH or a pharmaceutically acceptable salt, ester or amide thereof; B is a bond, a lower alkylene or oxygen; and R1 is hydrogen, halogen or a lower alkyl which is unsubstituted or substituted by halogen as an active ingredient. |